Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2Sarcoma 1Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1

Interventions

Blood Specimen Collection 35Methods 25Early Intervention, Educational 24Standard of Care 21Colposcopy 21Surveys and Questionnaires 19Educational Status 18Sentinel Lymph Node Biopsy 17Cisplatin 17Counseling 16Brachytherapy 16Exercise 15Interviews as Topic 13Carboplatin 13Therapeutics 12Surgical Procedures, Operative 11Paclitaxel 11Magnetic Resonance Spectroscopy 11Indocyanine Green 11Biopsy 11Radiotherapy 10Practice Guidelines as Topic 10Palliative Care 10Human Papillomavirus DNA Tests 10Behavior Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Psychiatric Rehabilitation 9Lymph Node Excision 9Genetic Testing 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Tissue Banks × Gynecologic × Clear all
NCT00298064 2023-07-05

Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer

University of New Mexico

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT02441140 2020-05-04

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Dana-Farber Cancer Institute

Phase NA Terminated
5 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡